🇺🇸 FDA

Drug profile · INN

hyaluronidase

VITRAGAN

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

hyaluronidase (VITRAGAN) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN hyaluronidase
Brand VITRAGAN
Route INJECTION
Formulation INJECTABLE
Originator Amphastar France Pharmaceuticals

Related patents

Search patents →

  1. US 12178860

    Hyaluronidase enzyme formulations for high volume administration

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11723959

    Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10898551

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10328130

    Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10286044

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9677062

    Hyaluronidase and factor VIII compositions

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9677061

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9562223

    Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)

    Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is hyaluronidase?

hyaluronidase (VITRAGAN) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for hyaluronidase?

VITRAGAN is a marketed brand name for hyaluronidase. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of hyaluronidase?

hyaluronidase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.